Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior
- 1 September 2011
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 131 (1-3) , 58-62
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Polypharmacy With Second-Generation Antipsychotics: A Review of EvidenceJournal of Psychiatric Practice, 2008
- Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory SchizophreniaThe Journal of Clinical Psychiatry, 2008
- Does the Addition of a Second Antipsychotic Drug Improve Clozapine Treatment?Schizophrenia Bulletin, 2008
- Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsSchizophrenia Bulletin, 2008
- Antipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?The Journal of Clinical Psychiatry, 2008
- Cost of antipsychotic polypharmacy in the treatment of schizophreniaBMC Psychiatry, 2008
- Benefits and Risks of Antipsychotic PolypharmacyDrug Safety, 2008
- Incidence and costs of polypharmacy: data from a randomized, double-blind, placebo-controlled study of risperidone and quetiapine in patients with schizophrenia or schizoaffective disorderCurrent Medical Research and Opinion, 2007
- Antipsychotic Polypharmacy Trends Among Medi-Cal Beneficiaries With Schizophrenia in San Diego County, 1999–2004Psychiatric Services, 2007
- Augmentation With a Second Antipsychotic in Patients With Schizophrenia Who Partially Respond to ClozapineJournal of Clinical Psychopharmacology, 2007